Beryl Capital Management’s CERo Therapeutics CERO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-271	Closed	-$5.57M	–	21
2022 Q4	$5.57M	Buy	+271	New	+$5.57M	2.24%	14
2022 Q2	–	Sell	-615	Closed	-$12.3M	–	69
2022 Q1	$12.3M	Hold	615	–	–	0.75%	25
2021 Q4	$12.2M	Buy	+615	New	+$12.2M	0.63%	31